Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

Jefferies analyst David Stanton maintained a Hold rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$304.00. The company’s shares closed yesterday at $232.96.

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

Morgan Stanley analyst Sean Laaman maintained a Sell rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$258.00. The company’s shares closed last Friday at $205.54.

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

S&P/ASX 200 Index (ASX: XJO) healthcare share Cochlear Ltd (ASX: COH) could be a leading performer over the coming years, if the broker UBS is correct. The broker UBS describes Cochlear as an ...

LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...

The Cochlear Ltd (ASX: COH) share price has struggled to regain momentum after a difficult year. The ASX healthcare stock finished Friday down 0.3% at $263.24. That is above its late-December low, but ...

BackgroundCochlear implants (CIs) are among the most successful neuroprosthetic technologies, restoring access to sound for individuals with ...